EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹2,348.00
arrow_upward
+1.45%(+33.60) 1D
Nov 13, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹2,325.00
High
₹2,395.00
Low
₹2,315.40
Mkt. cap
447.37B
Avg. vol.
229.26K
Volume
294.54K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.29
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
Open
₹2,325.00
High
₹2,395.00
Low
₹2,315.40
Mkt. cap
447.37B
Avg. vol.
229.26K
Volume
294.54K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.29
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
News stories
From web sources and news partners
TradingKey
·
6 hours ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
5 hours ago
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
TradingView
·
13 hours ago
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
13 hours ago
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com